Researchers identify molecule that blocks immune cells from entering and killing breast tumors

Researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. This research could pave the way toward a new treatment for certain kinds of aggressive breast cancer.

from Breast Cancer News -- ScienceDaily https://ift.tt/3k0fnbK

Chemo helps breast cancer cells get their ‘foot in the door’ to the lungs

A new study adds to the evidence that chemotherapy enhances cancer's spread beyond the primary tumor, showing how one chemo drug allows breast cancer cells to squeeze through and attach to blood vessel linings in the lungs.

from Breast Cancer News -- ScienceDaily https://ift.tt/3CPWpeY

Sperm switch swimming patterns to locate egg

A new study reveals how sperm change their swimming patterns to navigate to the egg, shifting from a symmetrical motion that moves the sperm in a straight path to an asymmetrical one that promotes more circular swimming.

from Women's Health News -- ScienceDaily https://ift.tt/3GEs9X1

Sperm switch swimming patterns to locate egg

A new study reveals how sperm change their swimming patterns to navigate to the egg, shifting from a symmetrical motion that moves the sperm in a straight path to an asymmetrical one that promotes more circular swimming.

from Women's Health News -- ScienceDaily https://ift.tt/3GEs9X1

Gene signature identifies drivers of treatment resistance in metastatic breast cancer

A multi-institution team of researchers has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.

from Women's Health News -- ScienceDaily https://ift.tt/2ZKdloZ

Gene signature identifies drivers of treatment resistance in metastatic breast cancer

A multi-institution team of researchers has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.

from Breast Cancer News -- ScienceDaily https://ift.tt/2ZKdloZ

Gene signature identifies drivers of treatment resistance in metastatic breast cancer

A multi-institution team of researchers has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.

from Women's Health News -- ScienceDaily https://ift.tt/2ZKdloZ

Bone mineral density decreases less than expected after menopause

Bone mineral density at the femoral neck bone in postmenopausal women decreased by an average of 10% during a 25-year follow-up, according to a new study. Being the world's hitherto longest follow-up of changes in bone mineral density in postmenopausal women, the study shows that bone loss after menopause is significantly lower than has previously been assumed on the basis of earlier studies.

from Women's Health News -- ScienceDaily https://ift.tt/De2hM7

Bone mineral density decreases less than expected after menopause

Bone mineral density at the femoral neck bone in postmenopausal women decreased by an average of 10% during a 25-year follow-up, according to a new study. Being the world's hitherto longest follow-up of changes in bone mineral density in postmenopausal women, the study shows that bone loss after menopause is significantly lower than has previously been assumed on the basis of earlier studies.

from Women's Health News -- ScienceDaily https://www.sciencedaily.com/releases/2021/10/211027122047.htm

Metabolic memory plays a key role in breast cancer relapse

Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of scientists who analyzed tumor cells that proved resistant to the original treatment. Recent advances in early detection and targeted therapy have led to a growing success in treating breast cancer upon first presentation. This often is achieved by silencing tumor driving oncogenes and causing tumor regression.

from Breast Cancer News -- ScienceDaily https://ift.tt/3nwecBB